fluoromethyl 2,2-difluoro-1-(trifluoromethyl)vinyl ether has been researched along with midazolam in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Carr, B; Kuo, Y; Li, C; Lin, JH; Lu, B; Prueksaritanont, T; Qiu, Y; Richards, K; Strong-Basalyga, K; Tang, C | 1 |
1 other study(ies) available for fluoromethyl 2,2-difluoro-1-(trifluoromethyl)vinyl ether and midazolam
Article | Year |
---|---|
In vitro and in vivo CYP3A64 induction and inhibition studies in rhesus monkeys: a preclinical approach for CYP3A-mediated drug interaction studies.
Topics: Adolescent; Adult; Aged; Animals; Cells, Cultured; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Drug Evaluation, Preclinical; Drug Interactions; Enzyme Induction; Enzyme Inhibitors; Ethers; Female; Hepatocytes; Humans; Hydrocarbons, Fluorinated; Hydroxylation; Infusions, Intravenous; Isoenzymes; Macaca mulatta; Male; Midazolam; Middle Aged; Models, Animal; Recombinant Proteins; Rifampin; RNA, Messenger | 2006 |